Correlations between cellular and soluble markers in the treatment with new polipeptide RUZAM in patients with allergic rhinitis

E. V. Shuvalova, A. V. Chernyak, Z. R. Aisanov, N. A. Kolganova, A. G. Chuchalin (Moscow, Russian Federation)

Source: Annual Congress 2005 - Current and emerging anti-inflammatory therapies
Session: Current and emerging anti-inflammatory therapies
Session type: Thematic Poster Session
Number: 2381
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. V. Shuvalova, A. V. Chernyak, Z. R. Aisanov, N. A. Kolganova, A. G. Chuchalin (Moscow, Russian Federation). Correlations between cellular and soluble markers in the treatment with new polipeptide RUZAM in patients with allergic rhinitis. Eur Respir J 2005; 26: Suppl. 49, 2381

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Changes in lung functions and inflammatory markers in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens
Source: Eur Respir J 2005; 26: Suppl. 49, 734s
Year: 2005

Inflammatory markers in induced sputum of patients with allergic rhinitis in relation to exposure to pollen allergens
Source: Eur Respir J 2006; 28: Suppl. 50, 444s
Year: 2006

Humoral markers of inflammation in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens
Source: Eur Respir J 2004; 24: Suppl. 48, 595s
Year: 2004

Local cytokine profile specifics among patients with BA phenotype, associated to allergic rhinitis: allergic rhinitis and bronchial asthma.
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018

Serum proteome analysis discriminates allergic rhinitis from asthma
Source: Annual Congress 2009 - Translational research/biomarkers
Year: 2009


Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011


Does allergens influence resistin levels in children with allergic rhinitis?
Source: Annual Congress 2012 - Aspects of clinical asthma
Year: 2012


IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status?
Source: International Congress 2017 – Monitoring asthma control
Year: 2017

The specific methods of immunotherapy in treatment of the patients with allergic seasonal rhinitis
Source: Eur Respir J 2002; 20: Suppl. 38, 507s
Year: 2002

Induced sputum levels of soluble receptor ST-2 in adult patients suffering from allergic asthma or allergic rhinitis
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016


Allergic inflammation markers for earlier diagnosis of bronchial asthma in patients with allergic rhinitis
Source: Annual Congress 2008 - Asthma: growing understanding of influential factors
Year: 2008


Inflammatory profile of patients with allergic asthma & rhinitis versus patients with allergic rhinitis alone
Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients
Year: 2007


Comparison of residual eosinophilic inflammation in the distal airway of patients with well-controlled asthma using different drug combinations of asthma treatment
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008

A decreased expression of leptin receptor may contribute to the pathogenesis of the allergic rhinitis
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010

Interactions between antiviral and atopic inflammatory pathways sustain asthma exacerbations in children
Source: Annual Congress 2009 - Infections, immunity and inflammation
Year: 2009

Immunotherapy prevents the development of asthma in subjects with allergic rhinitis
Source: Eur Respir J 2001; 18: Suppl. 33, 482s
Year: 2001

The diagnostic value of biomarkers in allergic and non-allergic asthma phenotype
Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Year: 2018


Effect of nasal allergen challenge on non-invasive markers of inflammation in allergic rhinitis
Source: Eur Respir J 2006; 28: Suppl. 50, 592s
Year: 2006

Persistency of treatment response to omalizumab in patients with severe allergic (IgE-mediated) asthma
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009


Cellular and biochemical changes induced by specific inhalation challenge test in bakers with allergic rhinitis and with bronchial asthma accompanied by rhinitis
Source: Eur Respir J 2004; 24: Suppl. 48, 369s
Year: 2004